Thomas A. Burke, Miriam C. Sturkenboom, Pamela A. Ohman-Strickland, Charles E. Wentworth, George G. Rhoads. The effect of antihypertensive drugs and drug combinations on the incidence of new-onset type-2 diabetes mellitus. Pharmacoepidemiology and Drug Safety. Published Online: 2 Jul 2007

————————————————–

Jara M, Lanes S, Wentworth C, May C, Kesten S. Comparative Safety of Long-Acting Inhaled Bronchodilators. Drug Safety, 2007; 30 (12): 1151-1160.

 ————————————————–

Arellano FM, Wentworth C, Arana A, Fernandez C, Paul C. Risk of lymphoma following exposure to calcineurin inhibitors and topical steroids in patients with atopic dermatitis. Journal of Investigative Dermatology, 2007; 127, 808-816.

————————————————–

Keston S, Jara M, Wentworth C, Lanes S. Pooled Clinical Trial Analysis of Tiotropium Safety. Chest, 2006; 130:1695-1703

————————————————–

Arellano FM, Yood M, Wentworth C, Oliveria S, Rivero E, Verma A, Rothman K. Use of cyclo-oxygenase 2 inhibitors (COX-2) and prescription non-steroidal anti-inflammatory drugs (NSAID) in UK and USA populations. Implications for COX-2 cardiovascular profile. Pharmacoepidemiology and Drug Safety 2006; 15: 861-872

————————————————–

Burke TA, Sturkenboom MC, Lu S, Wentworth CE, Lin Y, Rhoads GG. Discontinuation of antihypertensive drugs among newly diagnosed hypertensive patients in UK general practice. J Hypertens 2006; 24:1193–1200.

————————————————–

Zhao SZ, Wentworth C, Burke TA, Makuch RW. Drug Switching Patterns Among Patients With Rheumatoid Arthritis and Osteoarthritis Using COX-2 Specific Inhibitors and Non Specific NSAIDs. Pharmacoepidemiology and Drug Safety 2004, 13(5):277-287

————————————————–

Rothman KJ, CE Wentworth. Mortality of cystic fibrosis patients receiving tobramycin solution for inhalation. Epidemiology 2003, 14(1):55-59

————————————————–

Osterhaus, J, C May, T Burke, CE Wentworth. Physician-reported management of edema and destabilized blood pressure in COX-2 specific inhibitor users with OA and treated hypertension. Clinical Therapeutics, 2002; volume 24, number 6 (969-989)

————————————————–

Johnson ES, SF Lanes, CE Wentworth, MH Satterfield, BL Abebe, LW Dicker. A metaregression analysis of the dose-response effect of aspirin on stroke. Archives of Internal Medicine, 1999; 159:1248-1253

————————————————–

Lanes SF, JE Garrett, CE Wentworth, JM Fitzgerald, JP Karpel. The effect of adding nebulized ipratropium bromide to salbutamol (albuterol) in the treatment of acute asthma: a pooled analysis of three trials. Chest, 1998; 114:365-372

————————————————–

Lanes SF, LL Lanza, CE Wentworth. Risk of emergency care, hospitalization, and ICU stays for acute asthma among recipients158:857-861

————————————————–

Zhao SZ, Wentworth C, Burke TA, Makuch RW.Duration of Treatment with Celecoxib, Rofecoxib, and Non-Specific NSAIDs Among Managed Care Enrollees with Rheumatoid Arthritis and Osteoarthritis: A Measure of Comparative Drug Effectiveness. Value in Health, submitted.

————————————————– 

Zhao SZ, Wentworth C, Makuch RW. Re-Initiation of NSAIDs and COX-2 Specific Inhibitors Following Treatment Discontinuation Among Arthritis Patients in a US Managed Care Organization. Journal of General Internal Medicine, submitted.

download pdf